RealNetworks, Inc. (RNWK), an emerging leader in AI-based software and solutions, announced that it has received an unsolicited, non-binding proposal from Robert Glaser, RealNetworks’ Founder,

Radius Global Infrastructure Inc., (RADI) which leases cell sites to wireless-tower companies and mobile-network operators, is exploring strategic options including a sale, according to people

Kingstone Companies, Inc. (KINS), a Northeast regional property and casualty insurance holding company, confirmed that its Board of Directors received a preliminary non-binding indication of

Welltower Inc., (WELL) the big healthcare-focused real-estate investment trust, made a nearly $5 billion all-cash bid for Healthcare Realty Trust Inc. (HR) shortly after the

Sesen Bio (SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, announced that it has initiated a

Bright Scholar Education Holdings Limited (BEDU), a global premier education service company, announced that its board of directors has received a preliminary non-binding proposal letter

Argo Group International Holdings, Ltd. (ARGO) announced that its board of directors has initiated an exploration of strategic alternatives. As part of this process, the

Zymeworks Inc. (ZYME), a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, confirmed it has received an unsolicited, non-binding proposal from All Blue Falcons FZE (“ABF”)

Mattel Inc. (MAT) has held talks with private-equity firms including Apollo Global Management Inc. (APO) and L Catterton about a potential sale, people familiar with the matter

Silicon Motion Technology Corp. (SIMO) is exploring a potential sale amid takeover interest in the semiconductor firm, according to people familiar with the matter. Update(s):

Chindata Group Holdings Ltd., (CD) a Chinese data center company backed by private equity firm Bain Capital, has received preliminary takeover interest from other firms

Vallon Pharmaceuticals, Inc. (VLON), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter abuse in the treatment